Cervomed Inc (CRVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,353 | -2,458 | -6,850 | -23,026 | -8,400 |
| Depreciation Amortization | 7,237 | 2,054 | 1,588 | 1,980 | 50 |
| Income taxes - deferred | -2,817 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | 1,597 | 414 | -114 | N/A |
| Other Working Capital | -2,822 | 2,225 | 3,598 | 64 | 720 |
| Other Operating Activity | 3,725 | -4,602 | -3,061 | 9,072 | 5,650 |
| Operating Cash Flow | $-9,030 | $-1,185 | $-4,311 | $-12,025 | $-1,980 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -51 | N/A | N/A | -125 | -10 |
| Net Acquisitions | N/A | N/A | N/A | -861 | 0 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -1,370 |
| Investing Cash Flow | $-51 | $N/A | $N/A | $-986 | $-1,380 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 27 | -612 | N/A |
| Debt Issued | -1,140 | 700 | 3,483 | 388 | N/A |
| Debt Repayment | N/A | N/A | N/A | -63 | N/A |
| Common Stock Issued | 31,850 | 428 | 144 | 3,989 | N/A |
| Other Financing Activity | 0 | 0 | 870 | 9,406 | 3,360 |
| Financing Cash Flow | $30,710 | $1,128 | $4,524 | $13,109 | $3,360 |
| Beginning Cash Position | 255 | 312 | 98 | N/A | 0 |
| End Cash Position | 21,884 | 255 | 312 | 98 | 0 |
| Net Cash Flow | $21,629 | $-57 | $214 | $98 | $0 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,030 | -1,185 | -4,311 | -12,025 | -1,980 |
| Capital Expenditure | -51 | N/A | N/A | -125 | N/A |
| Free Cash Flow | -9,081 | -1,185 | -4,311 | -12,150 | -1,980 |